Even though SCCOHT was suspected based on the presence of polyphenotypic ovarian tumors in young females, the diagnosis was conclusively established by demonstration of loss of BRG1, and chemotherapy was immediately initiated. This evidence concerns the gene SMARCA4 and ovarian neoplasm.